![]() |
Lung Cancer |
Free Subscription
1 Am J Respir Crit Care Med |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Lung Cancer is free of charge.
Lung Cancer and the Environment.
Am J Respir Crit Care Med. 2025.
PubMed
ASO Visual Abstract: Difficult Decisions in the Multidisciplinary Treatment of
Resectable Non-small Cell Lung Cancer.
Ann Surg Oncol. 2025 May 26. doi: 10.1245/s10434-025-17521.
PubMed
Blood Concentrations of Osimertinib and Its Active Metabolites: Impact on
Treatment Efficacy and Safety.
Anticancer Res. 2025;45:2551-2561.
PubMed
Abstract available
High-dose third-generation EGFR-TKIs combined with intrathecal pemetrexed in
advanced EGFR-mutant NSCLC with leptomeningeal metastases following EGFR-TKI
therapy.
BMC Cancer. 2025;25:926.
PubMed
Abstract available
Innovations in modern low-LET radiotherapy regimens for locally advanced
non-small cell lung cancer: a meta-analysis and systematic review of
high-dose-rate brachytherapy, stereotactic body radiotherapy, and
hypofractionated proton therapy.
BMC Cancer. 2025;25:942.
PubMed
Abstract available
Impact of metabolic and nutritional disorders on the synergy between radiotherapy
and immunotherapy in non-small-cell lung cancer.
BMC Cancer. 2025;25:948.
PubMed
Abstract available
Photodynamic therapeutic activity of novel porphyrins against lung squamous cell
carcinoma.
BMC Cancer. 2025;25:960.
PubMed
Abstract available
Tracheal, bronchus, and lung cancer among older adults: thirty-year global burden
trends, precision medicine breakthroughs, and lingering barriers.
BMC Cancer. 2025;25:954.
PubMed
Abstract available
Epidemiology, patient management, and survival outcomes in resected patients with
non-metastatic non-small cell lung cancer: a nationwide real-world study.
BMC Cancer. 2025;25:966.
PubMed
Abstract available
Oligo-residual disease in metastatic ALK-positive NSCLC treated with alectinib.
Clin Exp Metastasis. 2025;42:31.
PubMed
Abstract available
A Propensity-Matched Comparison Between Minimally Invasive Surgery and
Stereotactic Radiotherapy in the Treatment of Clinical Stage IA Non-Small-Cell
Lung Cancer (NSCLC).
Clin Lung Cancer. 2025 Apr 29:S1525-7304(25)00083.
PubMed
Abstract available
Resection of 4 or more pulmonary segments increases the risk of
non-cancer-related mortality.
Eur J Cardiothorac Surg. 2025;67:ezaf162.
PubMed
Abstract available
[Corrigendum] Biological effects of BMP7 on small?cell lung cancer cells and its
bone metastasis.
Int J Oncol. 2025;66:51.
PubMed
Abstract available
Multisocietal Consensus on the Use of Cytoreductive Surgery and HIPEC for the
Treatment of Diffuse Malignant Peritoneal Mesothelioma: A GRADE Approach for
Evidence Evaluation and Recommendation.
J Surg Oncol. 2025;131:810-815.
PubMed
Abstract available
Lenvatinib Plus Pembrolizumab, Pemetrexed, and a Platinum as First-Line Therapy
for Metastatic Nonsquamous Non-Small-Cell Lung Cancer: Phase 3 LEAP-006 Study.
J Thorac Oncol. 2025 May 24:S1556-0864(25)00724.
PubMed
Abstract available
Safety and Sample Adequacy for Comprehensive Biomarker Testing of Bronchoscopic
Biopsies: An American Association of Bronchology and Interventional Pulmonology
(AABIP) and International Association for the Study of Lung Cancer (IASLC)
Clinical Practic
J Thorac Oncol. 2025 May 24:S1556-0864(25)00722.
PubMed
Abstract available
Expression of Membrane Targets for Therapeutics in RET-Positive Non-Small Cell
Lung Cancer.
JAMA Oncol. 2025 May 29. doi: 10.1001/jamaoncol.2025.1293.
PubMed
Abstract available
Coding Errors in Study of Lung Cancer Screening Guidelines and Adherence.
JAMA Oncol. 2025 May 29. doi: 10.1001/jamaoncol.2025.1624.
PubMed
Controlling nutritional status predicts postoperative survival and acute
exacerbation in resected non-small cell lung cancer with interstitial lung
disease.
Lung Cancer. 2025;205:108591.
PubMed
Abstract available
Early experience with PEF in the setting of recalcitrant stage IV lung cancer.
Lung Cancer. 2025;204:108575.
PubMed
Abstract available
A treatment-related death predictive score for treatment-naive advanced non-small
cell lung cancer.
Lung Cancer. 2025;204:108584.
PubMed
Abstract available
Colony-stimulating factor-1 receptor inhibitor augments osimertinib-induced
anti-tumor immunity via suppression of macrophages in lung cancer harboring EGFR
mutation.
Mol Cancer Ther. 2025 May 29. doi: 10.1158/1535-7163.MCT-25-0002.
PubMed
Abstract available
Molecular determinants of sotorasib clinical efficacy in KRAS(G12C)-mutated
non-small-cell lung cancer.
Nat Med. 2025 May 28. doi: 10.1038/s41591-025-03732.
PubMed
Abstract available
[Corrigendum] Sensitizing TRAIL?resistant A549 lung cancer cells and enhancing
TRAIL?induced apoptosis with the antidepressant amitriptyline.
Oncol Rep. 2025;54:87.
PubMed
Abstract available
The antiangiogenic peptide VIAN-c4551 inhibits lung melanoma metastasis in mice
by reducing pulmonary vascular permeability.
PLoS One. 2025;20:e0316983.
PubMed
Abstract available
Critical timing: Impact of delays to surgery on prognosis in stage I-II non-small
cell lung cancer.
PLoS One. 2025;20:e0319357.
PubMed
Abstract available
Explainable machine learning and feature interpretation to predict survival
outcomes in the treatment of lung cancer.
Semin Oncol. 2025;52:152364.
PubMed
Abstract available
Lung cancer risk assessment by prediction model: a global perspective.
Thorax. 2025 May 27:thorax-2023-221253. doi: 10.1136/thorax-2023-221253.
PubMed
Abstract available
Thank you for your interest in scientific medicine.